• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.15% Nasdaq Down 0.25%

    Cyclacel Pharmaceuticals, Inc. (CYCC)

    -NasdaqCM
    0.56 Up 0.01(1.78%) 3:05PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.55
    Open:0.54
    Bid:0.56 x 600
    Ask:0.56 x 9200
    1y Target Est:9.00
    Beta:4.79421
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:0.54 - 0.56
    52wk Range:0.49 - 3.72
    Volume:35,134
    Avg Vol (3m):169,863
    Market Cap:19.43M
    P/E (ttm):N/A
    EPS (ttm):-0.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYCC

    Comparison

    Symbol% ChgMkt Cap
    CYCCUp 1.78%19.43M
    JNJDown 0.88%256.23B
    AZNUp 1.75%81.49B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):10.66
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :N/A
    Quarterly EPS Est (Jun-15) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing small molecule drugs for the treatment of cancer and other serious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback